Studies showed that there is an increased expression of activation markers like CD11b/CD18 on monocytes and neutrophils in T2DM patients, resulting in increased neutrophil adhesiveness to the endothelium, independent of fasting glucose levels [52, 53]. The gene discussed is ITGB2; the disease is type 2 diabetes mellitus.